Jupiter Neurosciences Inc. (JUNS)
JUNS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.36
+10.53% on the day
Market cap
$4.4M
Nano cap
Revenue · 2025
$22K
No prior year to compare
Net income · 2025
-$8.6M
-39662.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | JUNS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001679628 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $22K |
| Net income | -$8.6M |
| Operating income | -$8.9M |
| Net margin | -39662.8% |
| Operating margin | -40873.2% |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | $5.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 203.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-09-25 |
| Latest annual report | 10-K | 2026-04-01 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-03 |
| Latest proxy | DEF 14A | 2026-06-22 |
Source: SEC EDGAR submissions feed, 202 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ENLV | Enlivex Ltd. | $0.2224 | -12.10% | $4.4M |
| NCNA | NuCana plc American Depositary Share | $1.05 | -2.78% | $4.4M |
| AZTR | Azitra Inc | $0.0715 | -39.20% | $4.3M |
| PPCB | Propanc Biopharma Inc. | $0.4125 | -6.25% | $4.3M |
| DRMA | Dermata Therapeutics Inc. | $0.8599 | -3.34% | $4.3M |
| LNAI | Lunai Bioworks Inc. | $1.03 | -7.21% | $4.7M |
| XTLB | XTL Biopharmaceuticals Ltd. | $1.98 | +3.12% | $4.9M |
| XBIO | Xenetic Biosciences Inc. | $2.10 | -0.94% | $4.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier